Ron3107 said...
Pratoman my mistake in the signature PSA was 4.79 at DX not 3.79 so I updated it. I realize the low PSA is probably not the reason for the pain but was mainly interested in the Avodart questions. I had L5 back surgery about 8 years ago to repair the disc, and was also told at that time that I was one of the few lucky ones who had an L6 which I believe is causing some of the low back pain. I was hoping the main symptoms were from the 53cc prostate and that the Avodart would reduce the size and hopefully the PSA. Which I hoped would reduce frequent urination, dribbling, stopping and starting etc. Thanks for your help.
.....................................................................................................................................................................................................................................................................................................................................................................
53 cc is not all that big, mine was 106. But, it is big enough to cause problems, and you might also have some prostatitis associated with it, causing problems. But the reason I am posting: last time I was at y URO, I saw a poster on the wall describing a new procedure they were doing. Rather than a TURP where they cut away excess prostate tissue, they now can go in with a minimally invasive surgery where they simply place some metal spacers which are pulled back by permanent sutures which tug on the spacers(or whatever they were called) which
opens the urethra where it was greatly narrowed by the enlarged prostate. That won't help with all of the symptoms of enlarged prostate and/or prostatitis, but it will about
cure the problems with difficulty passing urine. You might be interested in asking your doc about
Urolift:
https://www.healthline.com/health-news/men-less-invasive-treatment-for-bph-now-fda-approved-091913#3Somebody said...
One of the main benefits of UroLift is that it offers men with BPH a less-invasive option than open surgery, with no incisions and no cutting or burning away of the prostate tissue. In addition, the results of the procedure can be seen immediately afterwards.
The FDA review was based on two clinical studies of men with BPH who were implanted with two or more UroLift sutures. In both studies, surgeons were able to insert the sutures in 98 percent of cases.
The larger study, published in June in the Journal of Urology, involved 206 men with BPH. The procedure, which is done under local or general anesthesia, took 66 minutes to perform on average.
Twelve months after treatment, men with the UroLift sutures had improved urine flow and were better able to empty their bladders. They also reported a decrease in their symptoms and an increase in their quality of life.
Benefits and Risks of the New Treatment
Other minimally-invasive therapies for BPH also access the prostate through the urethra, making the UroLift system similar in this respect. The other procedures, however, involve cutting or burning away excess prostate tissue. UroLift uses only a needle and suture to pull back the prostate tissue.
UroLift is also less invasive than open surgery, a procedure that requires the surgeon to make an incision in the lower abdomen. open surgery has a greater risk of side effects, but is generally only used for men who have a very large prostate, damage to the bladder, or complicating conditions such as bladder stones.
The side effects reported by men treated with the UroLift system were all minor, and included:
pain or burning during urination
blood in urine
frequent or urgent need to urinate
incomplete emptying of the bladder
decreased flow of urine
Rare complications, however, can occur when the UroLift procedure—or any surgery—is done using general anesthesia, especially in older men or those with serious medical problems. Serious complications may include lung infections, temporary mental confusion, heart attack, stroke, or death.